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1. Introduction
One of the directions of 
research of the logistic system 
(LS) in developed countries is 
connected with the definition 
of the relationship of logistics 
and production costs, that is, the 
costs of warehouse and transport 
facilities, inventories, produc-
tion, processing orders and other 
components of the company’s LS, 
which depend on each other. At-
tempts to minimize the costs of a 
particular activity can lead to an 
increase in the total cost of logis-
tics. For example, at the logistics 
stage, efforts have traditionally 
been aimed at minimizing costs 
for the purchase of substances 
and materials, at the stage of 
production – to minimize costs 
for the production of a series of 
drugs (medicines); at the stage 
of transportation – to increase 
the use of vehicles. The concept 
of logistics management involves 
an analysis of the innovations of 
any function, taking into account 
the total cost of the entire drug.
The urgency of studying and 
improving the management of 
logistics costs (LC) is due also 
to their significant share in the 
structure of the cost of goods. 
According to Michael R. Lyn-
ders, the share of LC in the value 
of goods is about 30 % in the food 
industry, 26–27 % in the chemi-
cal industry (including pharma-
ceuticals), 16 % in the manufac-
ture of electronic and electrical 
products [1] . Interestingly, there 
is also data on the share of LC 
in the gross domestic product of 
different countries. For example, 
in the USA it is 11.4 %, in Japan it 
is 11.4 %, in the United Kingdom 
it is 11.5 %, in France 11.5 %, in 
Canada 11.9 %, in Spain 12.0 %, 
in Denmark – 13 %, in Germany – 
13.5 %, in Mexico – 15.4 % [2]. 
According to the famous logistics 
specialist R. Ball, LC in developed 
countries are on average 12 % of 
GNP [3]. 
Today, often the desire to 
achieve the partial goals of indi-
vidual units of the LS leads to an 
increase in the general LC, due to 
the lack of methodological and 
methodic research in the field of management and, accordingly, 
requires the creation of a modern mechanism. The condition for 
its creation is the acquisition of the SFG effect due to the coordi-
nation and optimization of costs throughout the LFL, the transi-
tion from the local management 
objectives of the LC to their man-
agement, taking into account the 
general objectives of LS; improve-
ment of normative and informa-
tional support of this process. In 
addition, the need to develop a 
modern management mechanism 
of LC is associated with their sig-
nificant impact on the size of en-
terprise revenue [1–11].
The aim of the study is to de-
termine the factors influencing 
the magnitude of the logistics.
2. Materials and methods
The methods used in the study 
include the expert, systematic me- 
thod of scientific knowledge and 
the method of abstract modeling.
The systemic method of sci-
entific knowledge and structural 
analysis was used in the process 
of analyzing the current state of 
managing the logistics costs of 
the pharmaceutical industry. The 
method of abstract modeling was 
used in the process of conclu-
sions preparation.
An expert method was con-
ducted with the help of question-
naires of specialists of pharmaceu-
tical companies, pharmacies and 
wholesale pharmaceutical compa-
nies. 118 respondents participated 
in the survey, their characteristics 
are shown in the Table 1.
Table 1
Characteristics of experts who 
participated in the survey
Characteristics
The direction 
of the sur- 
vey – logistics 
costs
Number of experts 118
Employment period:
– up to 5 years 18
– from 5 to 10 years 12
– from 10 to 20 years 70
– more than 20 years 18
Education: 
– advanced education 2
– higher education 116
Place of work:
– ZOZ -
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Abstract: Aim: to determine the factors of influence on the 
magnitude of logistics costs and developing measures to min-
imize them.
Materials and methods. The methods used in the study in-
clude the expert, systematic method of scientific knowledge, 
structural analysis, the method of abstract modeling. An expert 
method was conducted with the help of questionnaires of spe-
cialists of pharmaceutical companies, pharmacies and whole-
sale pharmaceutical companies. 118 respondents participated 
in the survey. The degree of consistency of expert opinions was 
determined with the help of the coefficient of concordance, 
which is 0.8374 (the normative value of the coefficient of con-
cordance is 0.75), the Pearson criterion also exceeds the table 
value for the corresponding number of degrees of freedom, 
which testifies to the non-randomness of their judgments.
Results. The factors influencing the amount of logistics costs 
are determined. The internal factors of influence include the 
activities of the subject of the pharmaceutical industry, assort-
ment structure and structure of the use of substances and mate-
rials, the magnitude of stocks, etc. External factors of influence 
are the level of prices for logistics services provided by outside 
organizations; rate of transport tax; environmental taxes etc.; 
competitors suppliers of substances and materials; consumers; 
intermediaries; legislative base, etc. The conducted question-
ing of specialists and taking into account the current experi-
ence of leading foreign pharmaceutical companies allowed to 
determine the main measures to minimize logistics costs for 
all parts of the logistics system – procurement, production, 
transportation, storage, distribution and recycling, and types 
of flows – material, financial, information, labor.
Conclusions. Based on the carried out research, the factors in-
fluencing the magnitude of logistics costs, which experts are 
divided into external and internal, are determined. The matrix 
of the components of LV savings is proposed, which takes into 
account the type of flow and the links of the logistic system. 
The constructed matrix allows to minimize the amount of LV, 
which helps to reduce the price of drugs for the end user.
Keywords: logistics costs, subjects of the pharmaceutical in-
dustry, factors of influence, logistic system, matrix of com-
ponents of logistics cost savings, medicines, flows, pharma-
ceutical industry.
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The degree of consistency of expert opinions is not coinci-
dental, so, the coefficient of concordance is 0.8374 (normative 
value – 0.75), the Pearson criterion exceeds the table value for 
the corresponding number of degrees of freedom.
3. Result
The analysis highlighted the complexity of LC, in connection 
with which there is a need to develop measures to minimize them. 
Implementation of the LC management system for pharmaceuti-
cal industry subjects (PIS) requires the establishment of feedback 
“pharmaceutical market – LC PIS”, which in turn promotes the 
search for reserves to improve the effectiveness of the LFS and 
the level of satisfaction of drug consumers. The factors affecting 
the size of LC should be divided into internal (PIS activities, 
assortment structure and structure of the use of substances and 
materials, the size of stocks, etc.) and external (the price level for 
logistics services provided by outside organizations, the rate of 
transport tax, environmental taxes, etc., competitors; suppliers of 
substances and materials, consumers, intermediaries, legislative 
base, etc.). The histogram of the distribution of the ranks of the 
factors of influence on the value of LC, determined on the basis 



























Fig. 1. Distribution histogram in terms of the significance of the factors affecting the magnitude of the logistics costs of the PIS:  
X1 – the scope of the PIS; X2 is the degree of complexity of the assortment structure of the PIS and the structure of the use of 
materials; X3 – production structure of PIS; X4 – the value of inventories of material resources (MR); Х5 – level of novelty and 
equipment status; X6 – level of novelty of technologies; Х7 – qualification of the personnel; Х8 – organization of processes of physical 
movement of materials at the enterprise, etc.); Х9 – level of prices for logistic services provided by third parties; Х10 – rate of 
crediting of capital attracted for financing of logistic activity; X11 – competitors; X12 – suppliers; Х13 – quantity of deliveries of  
















































































































































































































































































































































































































































































































































































































Fig. 2. Classification of factors of influence on the magnitude of the logistics costs of micro-LFS
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An important point in LC management is the development 
of measures to minimize their magnitude. The results of the ma-
trix analysis of components of economy of LC of different levels 
constructed on the basis of different levels are given in Table 2.
Table 2
The matrix of the components of the logistics cost savings in the pharmaceutical industry
Type of flows
Links of LFS
purchase production warehousing distribution transportation recycling
Material
Savings due to 
optimization 
of procure-
ment of drugs, 
substances




Savings due to lower costs for the storage of 
drugs, substances and materials
Savings due to improved quality 
of transportation planning in 
conditions of uncertainty
Savings due to 
the creation of 
RLFCV
Saving thanks to the optimiza-
tion of the range of drugs
Saving thanks to optimizing the location of phar-
maceutical compositions





Savings due to optimization of MR stocks
Savings due 
to the selec-
tion of the 
best suppliers
Saving by reducing losses due to lack of stocks
Savings due to the optimal use 
of warehouse space through 
the integration of PSI actions
Savings 




Savings due to the creation of CL
Saving due to the creation of regional pharmaceutical logistics warehouses
Saving by reducing losses, damage, confiscation and falsification of drugs
Saving due to MR balance according to GpP rules
Savings due to the use of outsourcing in pharmacy
Savings due to the reduction of all phases of the LFL life cycle (R&D, materials and materials supply, drug production, order pro-
cessing, distribution, etc.)
Savings due to the use of different forms of integration of suppliers of substances and materials, pharmaceutical manufacturers and 
consumers of medicines, information organizations, intermediaries, etc.
Savings due to the creation of the FRK
Saving through the search and reduction of those types of activities (procedures, works, operations) that do not create added value 
by analyzing and reviewing the LFL
Savings due to the creation of industry stocks in the case of epidemics, natural disasters, etc.
Saving thanks to the creation of an organizational vertical flow control in the pharmaceutical industry
Financial
Saving by reducing the immobilization of financial resources in stocks
Reducing costs caused by violations of the conditions of delivery of drugs, substances and materials
Saving by reducing losses due 
to environmental insuranceSavings due to reduced losses due to stock insurance
Savings due to reduced losses due to cargo insurance
Reduction of losses, damage, falsification and confiscation of drugs
Informational
Reducing the time by combining the LFS units into a single IC and improving the coherence of their actions

















Reducing costs by optimizing 






Reduce costs by optimizing the 
recycling business database 
Labor
Reduce time and costs due to the high quality of logistics workers
Savings due to improved customs clearance
Savings due to customer business development programs, workshops for dealers, etc.
Saving due to the improvement of LV accounting methods
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4. Discussion
On the basis of the study, it was determined that the value 
of LC is significantly influenced by both external and internal 
factors. To external factors experts include the environment 
PIS, namely, suppliers of substances and materials, compet-
itors, consumers of medicines, intermediaries, third-party 
organizations; the level of prices for logistics services, the 
legislative base and others. Internal factors of influence are the 
scope of the PIS, the assortment structure and structure of the 
use of substances and materials, the magnitude of stocks, etc. 
At the same time, factors such as the scope of PIS activity, staff 
qualifications, the degree of complexity of the PIS assortment 
structure, and the structure of the use of materials, as well as 
the magnitude of stocks, need to be given special attention 
because they have the greatest impact on the magnitude of LC.
A prerequisite for the effective functioning of PIS is the 
economy of LC, for which a matrix of components of LC sav-
ings was created taking into account the type of f low (material, 
financial, information, labor) and the links of the logistics sys-
tem (procurement, production, transportation, warehousing, 
distribution and recycling).
The proposed measures differ from existing ones taking 
into account all types of PIS activities and types of f lows, as 
well as the peculiarities of functioning of both PIS and its 
suppliers, consumers and competitors. Thus, for example, 
B. P. Hromovik allocates expenses related to the purchase, 
sale, transportation and storage of drugs [5]. Due to the di-
versity of LC, the definition of approaches and methods for 
managing them is urgent today. M. Lewis, J. Calliton and 
J. Styl have taken the concept of total logistics costs [8], ac-
cording to which the total costs include all the costs necessary 
to meet the needs of logistics. Within the framework of this 
concept, a strategy is made to minimize overall costs, aimed 
at creating LS with the lowest constant and variable costs. 
The disadvantage of this approach is the use of common LC 
as a key indicator in the formation of a logistics strategy, and 
for domestic business conditions - the inability of the cur-
rent accounting and statistical reporting system to allocate 
components of LC, the existence of “double” accounting, the 
secrecy of financial information for partners and even for 
structural divisions inside PIS and others, lack of methods 
for calculating losses from logistic risks, etc. Thus, these 
measures will allow PIS not only to maximize the profits it 
receives, but also minimize the costs of transportation and 
storage of drugs, which will ultimately positively affect the 
price of medicines for the consumer.
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